STOCK TITAN

RF Acquisition III Rights (RFAMR) 10-Q Filings

RFAMR NASDAQ

Here are the 10-Q quarterly reports from RF Acquisition Corp III Rights (RFAMR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow RFAMR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RFAMR filings page.

Rhea-AI Summary

RF Acquisition Corp III, a Cayman Islands SPAC, reports early-stage results for the quarter ended June 30, 2026 after completing its IPO in February 2026. The company sold 10,000,000 units at $10.00 each, and together with a 350,000-unit private placement, placed $100,000,000 into a U.S.-based trust account.

As of June 30, 2026, cash held in the trust account was $101,273,496, reflecting interest income, while cash outside the trust was $891,600 and shareholders’ equity was $595,740. The SPAC recorded net income of $566,737 for the quarter and $1,239,770 for the nine months, driven mainly by $870,264 and $1,273,496, respectively, of interest on trust assets and a $422,000 gain from derecognition of an over-allotment option liability, partially offset by general and administrative costs.

The trust backs 10,000,000 public shares classified as redeemable at $10.13 per share. The company has 21 months from the IPO closing to complete a business combination. On July 9, 2026, it signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., valuing HCC Healthcare at a fully diluted equity value of $500,000,000; RF Acquisition Corp III will merge into a HCC Healthcare subsidiary, and each SPAC share will convert into HCC Healthcare shares, with each right converting into one-tenth of a share, subject to customary closing conditions.